IP Library Granted Patent US 9,622,693
Granted Patent B2
US 9,622,693 · App. 14/609,841 · Granted Apr 18, 2017

Systems and methods for determining blood oxygen saturation values using complex number encoding

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,622,693
App. No.
14/609,841
Granted
Apr 18, 2017
Kind
B2
Abstract

The disclosure includes pulse oximetry systems and methods for determining point-by-point saturation values by encoding photoplethysmographs in the complex domain and processing the complex signals. The systems filter motion artifacts and other noise using a variety of techniques, including statistical analysis such as correlation, or phase filtering.

Claims (26)

1. A physiological monitor that computes arterial oxygen saturation in tissue material, the physiological monitor comprising:

a light emitter which emits light of at least first and second wavelengths;

a light detector responsive to light from said light emitter attenuated by body tissue, said light detector providing an output signal indicative of at least first and second intensity signals associated with said at least first and second wavelengths; and

one or more hardware processors programmed to encode the first and second intensity signals in a complex domain; filter artifacts based on the complex encoding of the first and second intensity signals; compute arterial oxygen saturation from the filtered complex encoding of the first and second intensity signals; and output the calculated arterial oxygen saturation.

2. The physiological monitor of claim 1 , wherein the filtering of artifacts comprises filtering ratios corresponding to the encoded first and second intensity signals.

3. The physiological monitor of claim 2 , wherein the filtering comprises using a phase filter including a first range of phases.

4. The physiological monitor of claim 3 , wherein the first range of phases comprise phase angles from about −2.0 to about 3.0 degrees.

5. The physiological monitor of claim 3 , wherein the first range of phases comprise phase angles from about 0 to about 1 degree.

6. The physiological monitor of claim 2 , wherein the filtering comprises using a weighing filter on a continuous stream of instantaneous ratios corresponding to the first and the second intensity signals.

7. The physiological monitor of claim 1 , wherein the complex domain comprises complex time domain.

8. The physiological monitor of claim 1 , wherein the complex domain comprises complex frequency domain.

9. The physiological monitor of claim 1 , wherein the one or more hardware processors are further programmed to determine a plurality of ratios over time from the first and the second intensity signals.

10. The physiological monitor of claim 1 , wherein the artifacts comprise motion artifacts.

11. The physiological monitor of claim 1 , wherein the artifacts comprise venous pulsation.

12. A physiological monitoring method for computing arterial oxygen saturation in tissue material, the physiological monitor method comprising:

driving a light emitter configured to emit light of at least first and second wavelengths;

receiving an output signal indicative from a light detector of at least first and second intensity signals associated with said at least first and second wavelengths;

encoding the first and second intensity signals in a complex domain;

filtering artifacts from the complex encoding of the first and second intensity signals;

computing arterial oxygen saturation based on the filtered complex encoding of the first and second intensity signals; and

output the computed arterial oxygen saturation.

13. The physiological monitoring method of claim 12 , wherein the filtering comprises using a phase filter including a first range of phases.

14. The physiological monitoring method of claim 13 , wherein the first range of phases comprise phase angles from about −2.0 to about 3.0 degrees.

15. The physiological monitoring method of claim 12 , wherein the filtering comprises using a weighing filter on a continuous stream of instantaneous ratios corresponding to the first and the second intensity signals.

16. The physiological monitoring method of claim 12 , further comprising determining a plurality of ratios over time from the first and the second intensity signals.

17. The physiological monitoring method of claim 12 , wherein the artifacts comprise motion artifacts.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2016
From: CERCACOR LABORATORIES, INC.
To: MASIMO CORPORATION
Reel/Frame 038049/0074 →